vs
EOG资源（GURE）与Immunovant, Inc.（IMVT）财务数据对比。点击上方公司名可切换其他公司
EOG资源的季度营收约是Immunovant, Inc.的1.1倍（$9.0M vs $8.4M），EOG资源净利率更高（-394.3% vs -899.0%，领先504.7%），EOG资源同比增速更快（303.4% vs 140.7%）
EOG资源是一家美国能源企业，主营业务为油气勘探开发。公司注册于特拉华州，总部位于德克萨斯州休斯顿的传统广场大厦，是美国本土重要的独立油气生产商之一。
Immunovant是一家临床阶段生物制药企业，专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法，其核心在研候选产品覆盖多种自身免疫适应症，面向全球医疗市场布局研发管线。
GURE vs IMVT — 直观对比
营收规模更大
GURE
是对方的1.1倍
$8.4M
营收增速更快
GURE
高出162.6%
140.7%
净利率更高
GURE
高出504.7%
-899.0%
损益表 — Q3 FY2025 vs Q4 FY2024
| 指标 | | |
|---|---|---|
| 营收 | $9.0M | $8.4M |
| 净利润 | $-35.7M | $-75.3M |
| 毛利率 | — | — |
| 营业利润率 | -3.7% | -896.2% |
| 净利率 | -394.3% | -899.0% |
| 营收同比 | 303.4% | 140.7% |
| 净利润同比 | -921.1% | -26.7% |
| 每股收益（稀释后） | — | $-0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GUREIMVT
| Q3 25 | $9.0M | — | ||
| Q2 25 | $8.3M | — | ||
| Q1 24 | — | $8.4M | ||
| Q4 23 | $6.9M | $8.9M | ||
| Q3 23 | $5.9M | $3.6M | ||
| Q2 23 | $8.0M | $4.1M | ||
| Q1 23 | $9.3M | $3.5M | ||
| Q4 22 | $18.6M | $2.9M |
净利润GUREIMVT
| Q3 25 | $-35.7M | — | ||
| Q2 25 | $-773.8K | — | ||
| Q1 24 | — | $-75.3M | ||
| Q4 23 | $-58.8M | $-51.4M | ||
| Q3 23 | $-1.8M | $-58.7M | ||
| Q2 23 | $-681.8K | $-73.9M | ||
| Q1 23 | $-557.7K | $-59.4M | ||
| Q4 22 | $-2.7M | $-63.2M |
毛利率GUREIMVT
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | 8.5% | — | ||
| Q1 23 | 27.2% | — | ||
| Q4 22 | — | — |
营业利润率GUREIMVT
| Q3 25 | -3.7% | — | ||
| Q2 25 | -9.0% | — | ||
| Q1 24 | — | -896.2% | ||
| Q4 23 | -114.7% | -576.8% | ||
| Q3 23 | -39.1% | -1629.6% | ||
| Q2 23 | -11.5% | -1819.1% | ||
| Q1 23 | -8.6% | -1736.3% | ||
| Q4 22 | -2.7% | -2134.5% |
净利率GUREIMVT
| Q3 25 | -394.3% | — | ||
| Q2 25 | -9.3% | — | ||
| Q1 24 | — | -899.0% | ||
| Q4 23 | -855.6% | -575.6% | ||
| Q3 23 | -30.3% | -1642.3% | ||
| Q2 23 | -8.5% | -1818.9% | ||
| Q1 23 | -6.0% | -1707.8% | ||
| Q4 22 | -14.5% | -2147.7% |
每股收益（稀释后）GUREIMVT
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 24 | — | $-0.50 | ||
| Q4 23 | — | $-0.36 | ||
| Q3 23 | — | $-0.45 | ||
| Q2 23 | — | $-0.57 | ||
| Q1 23 | — | $-0.46 | ||
| Q4 22 | — | $-0.49 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $635.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $107.5M | $617.8M |
| 总资产 | $131.9M | $666.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GUREIMVT
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 24 | — | $635.4M | ||
| Q4 23 | $72.2M | $690.9M | ||
| Q3 23 | — | $269.9M | ||
| Q2 23 | — | $330.0M | ||
| Q1 23 | — | $376.5M | ||
| Q4 22 | — | $432.6M |
股东权益GUREIMVT
| Q3 25 | $107.5M | — | ||
| Q2 25 | $142.2M | — | ||
| Q1 24 | — | $617.8M | ||
| Q4 23 | $205.2M | $679.3M | ||
| Q3 23 | $260.7M | $251.8M | ||
| Q2 23 | $260.3M | $299.9M | ||
| Q1 23 | $274.8M | $362.5M | ||
| Q4 22 | $271.6M | $414.7M |
总资产GUREIMVT
| Q3 25 | $131.9M | — | ||
| Q2 25 | $164.6M | — | ||
| Q1 24 | — | $666.4M | ||
| Q4 23 | $226.7M | $711.4M | ||
| Q3 23 | $278.9M | $292.1M | ||
| Q2 23 | $278.3M | $351.2M | ||
| Q1 23 | $295.7M | $405.8M | ||
| Q4 22 | $292.4M | $456.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.7M | $-59.7M |
| 自由现金流经营现金流 - 资本支出 | — | $-59.8M |
| 自由现金流率自由现金流/营收 | — | -714.4% |
| 资本支出强度资本支出/营收 | — | 1.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-214.6M |
8季度趋势，按日历期对齐
经营现金流GUREIMVT
| Q3 25 | $6.7M | — | ||
| Q2 25 | $-559.3K | — | ||
| Q1 24 | — | $-59.7M | ||
| Q4 23 | $-42.6M | $-47.1M | ||
| Q3 23 | $-1.1M | $-60.1M | ||
| Q2 23 | $6.2M | $-47.4M | ||
| Q1 23 | $4.8M | $-55.8M | ||
| Q4 22 | $14.0M | $-46.4M |
自由现金流GUREIMVT
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 24 | — | $-59.8M | ||
| Q4 23 | — | $-47.2M | ||
| Q3 23 | $-16.3M | $-60.1M | ||
| Q2 23 | $6.2M | $-47.4M | ||
| Q1 23 | $4.8M | $-55.8M | ||
| Q4 22 | $9.7M | $-46.5M |
自由现金流率GUREIMVT
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 24 | — | -714.4% | ||
| Q4 23 | — | -528.7% | ||
| Q3 23 | -277.7% | -1682.4% | ||
| Q2 23 | 77.0% | -1166.4% | ||
| Q1 23 | 51.6% | -1604.0% | ||
| Q4 22 | 52.2% | -1579.2% |
资本支出强度GUREIMVT
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 24 | — | 1.8% | ||
| Q4 23 | — | 1.5% | ||
| Q3 23 | 258.3% | 1.0% | ||
| Q2 23 | 0.2% | 1.1% | ||
| Q1 23 | 0.4% | 0.7% | ||
| Q4 22 | 23.4% | 3.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GURE
| Bromine | $8.1M | 89% |
| Shandong Shouguang Shenrunfa Marine Chemical Company Limited | $1.4M | 15% |
IMVT
暂无分部数据
